GU CONNECT

GU CONNECT is an international group of experts in the field of genitourinary oncology and is an initiative of COR2ED. The group discusses the latest scientific and clinical insights, identifies educational needs, and develops educational programmes to support healthcare professionals globally to provide the best possible care to their patients.

GU CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from AstraZeneca, Bayer and Eisai Europe Limited.

Meet the GU CONNECT experts

What’s new from GU CONNECT

video Video

Episode

2

of 2

episode
Oncology 
Clinical Implementation of Testing and PARPi as Monotherapy or in Combination with NHAs – Episode 2

Clinical implementation of testing and PARP inhibitors in combination with NHAs

Experts
Dr Neal Shore, Dr Andrew J. Armstrong
Endorsed by
ZERO NASPCC
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Jul 2023
GU CONNECT Non-accredited Independent Medical Education
Educational programme supported by an Independent Educational Grant from AstraZeneca
video Video

Episode

1

of 2

episode
Oncology 
Clinical Implementation of Testing and PARPi as Monotherapy or in Combination with NHAs – Episode 1

Clinical implementation of testing and PARPi monotherapy

Experts
Dr Neal Shore, Dr Andrew J. Armstrong
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Jul 2023
COR2ED
Brought to you by COR2ED Medical Affairs in collaboration with AstraZeneca
video Video
Oncology 
Update from ASCO 2023: Late-Breaking RCC Data

Prof. Thomas Powles shares his perspective on key RCC data

Experts
Prof. Thomas Powles
  • download Downloadable
    Resources
  • clock 3 MIN
  • calendar Jun 2023
GU CONNECT Non-accredited Independent Medical Education
Educational programme supported by an Independent Educational Grant from Eisai Europe Limited
podcast Podcast
Oncology 
Which mCSPC patients benefit from early treatment intensification?

A podcast from GU oncology experts

Experts
Assoc. Prof. Shilpa Gupta, Dr Fabio Schutz
Endorsed by
ZERO
  • download Downloadable
    Resources
  • clock 22 MIN
  • calendar Mar 2023
GU CONNECT Non-accredited Independent Medical Education
Educational programme supported by an Independent Educational Grant from Bayer
podcast Podcast

Episode

3

of 3

episode
Oncology 
Podcast: PARP inhibitors alone or in combination with novel hormonal agents in prostate cancer – Episode 3

Episode 3: Overview of efficacy and safety data of combination therapy with PARPi and NHAs, incorporating the latest data presented and the impact for the treatment of patients with mCRPC

Experts
Dr Neal Shore, Dr Elena Castro, Prof. Neeraj Agarwal, Assoc. Prof. Tanya Dorff
  • download Downloadable
    Resources
  • clock 22 MIN
  • calendar Feb 2023
GU CONNECT Non-accredited Independent Medical Education
Educational programme supported by an Independent Educational Grant from AstraZeneca
podcast Podcast

Episode

2

of 3

episode
Oncology 
Podcast: PARP inhibitors alone or in combination with novel hormonal agents in prostate cancer – Episode 2

Episode 2: Clinical implementation of PARPi and NHA combination therapy for patients with mCRPC – a US and EU perspective

Experts
Dr Neal Shore, Dr Elena Castro, Prof. Neeraj Agarwal, Assoc. Prof. Tanya Dorff
  • download Downloadable
    Resources
  • clock 20 MIN
  • calendar Feb 2023
GU CONNECT Non-accredited Independent Medical Education
Educational programme supported by an Independent Educational Grant from AstraZeneca
Load more Explore all our programmes